BioAtla, Inc.

Nasdaq:BCAB

Biological Products, (No Diagnostic Substances)·SAN DIEGO, CA

Financials

20 shown

Type	Period	Ended	Filed
10-Q	Q3 2025	9/30/25	11/13/25	→
10-Q	Q2 2025	6/30/25	8/7/25	→
10-Q	Q1 2025	3/31/25	5/6/25	→
10-K	FY 2024	12/31/24	3/28/25	→
10-Q	Q3 2024	9/30/24	11/7/24	→
10-Q	Q2 2024	6/30/24	8/8/24	→
↓

Earnings Releases (8-K)

16 shown

Filed	Period
3/2/26	Q1 FY2026	→
11/13/25	Q4 FY2025	→
8/7/25	Q3 FY2025	→
5/6/25	Q2 FY2025	→
3/27/25	Q1 FY2025	→
11/7/24	Q4 FY2024	→
↓

News (8-K)

43 shown

Filed	Type	Description
2/9/26	Other	Other Events	→
2/6/26	Delisting	Notice of Delisting or Failure to Satisfy a Continued Listing Rule	→
1/30/26	Reg FD	Amendments to Articles of Incorporation or Bylaws	→
1/12/26	Vote	Unregistered Sales of Equity Securities	→
12/31/25	Agreement	Entry into a Material Definitive Agreement	→
12/30/25	Vote	Submission of Matters to a Vote of Security Holders	→
↓

Prospectuses & Registrations

27 shown

Filed	Form	Description
1/16/26	S-3	S-3	→
11/21/25	424B5	424B5	→
5/16/25	424B3	424B3	→
5/6/25	S-3	S-3	→
4/24/25	ARS	ARS	→
3/28/25	S-8	S-8	→
↓

Filing History(478 filings)

TypeDateAccessionPeriodSize

Mar 2, 2026

0001193125-26-0859714

Feb 28, 2026

8.5 KB

Mar 2, 2026

0001193125-26-0859704

Feb 28, 2026

4.6 KB

Mar 2, 2026

0001193125-26-0859684

Feb 28, 2026

4.7 KB

Mar 2, 2026

0001193125-26-0859664

Feb 28, 2026

4.6 KB

DEFA14A

Mar 2, 2026

0001539497-26-000813DEFA14A

—

337.4 KB

8-K

Mar 2, 2026

0001539497-26-000812FORM 8-K

Feb 24, 2026

268.6 KB

DEFM14A

Feb 11, 2026

0001539497-26-000331DEFM14A

—

502.2 KB

8-K

Feb 9, 2026

0001193125-26-0418528-K

Feb 8, 2026

137.7 KB

8-K

Feb 6, 2026

0001193125-26-0413678-K

Feb 6, 2026

162.3 KB

PREM14A

Jan 30, 2026

0001539497-26-000230PREM14A

Jan 30, 2026

2.3 MB

8-K

Jan 30, 2026

0001193125-26-0319428-K

Jan 26, 2026

333.3 KB

S-3

Jan 16, 2026

0001193125-26-015344S-3

—

1.3 MB

DEFA14A

Jan 15, 2026

0001193125-26-013845DEFA14A

—

523.8 KB

8-K

Jan 12, 2026

0001193125-26-0104588-K

Jan 9, 2026

201.1 KB

DEFA14A

Dec 31, 2025

0001193125-25-338402DEFA14A

—

16.7 KB

8-K

Dec 31, 2025

0001193125-25-3376468-K

Dec 30, 2025

182.0 KB

8-K

Dec 30, 2025

0001193125-25-3370788-K

Dec 30, 2025

162.8 KB

DEF 14A

Dec 5, 2025

0001539497-25-003176DEF 14A

Dec 5, 2025

3.5 MB

Dec 1, 2025

0001193125-25-3041784

Nov 30, 2025

4.8 KB

Dec 1, 2025

0001193125-25-3041734

Nov 30, 2025

4.6 KB

Dec 1, 2025

0001193125-25-3041714

Nov 30, 2025

8.5 KB

Dec 1, 2025

0001193125-25-3041704

Nov 30, 2025

4.7 KB

PRE 14A

Nov 24, 2025

0001193125-25-292058PRE 14A

Nov 24, 2025

373.0 KB

424B5

Nov 21, 2025

0001193125-25-290676424B5

—

565.7 KB

8-K

Nov 21, 2025

0001193125-25-2904748-K

Nov 20, 2025

1.6 MB

25 filings shown

Filed	Form	Description
10/15/25	SCHEDULE 13G	SCHEDULE 13G	→
5/20/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
5/14/25	EFFECT	EFFECT	→
4/25/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
3/18/25	SCHEDULE 13G	SCHEDULE 13G	→
2/10/25	SCHEDULE 13G	SCHEDULE 13G	→
↓

BioAtla, Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(478 filings)

Proxies

Ownership

Other Filings